Objective: The Flow Cytometry Shared Resource (FCSR) supports translational and clinical cancer research projects of University of Colorado Cancer Center (UCCC) members with flow cytometric analysis, high-speed cell sorting, microscopy, and multiplexed fluorescent microsphere assays. Services and Technologies: FCSR provides a wide range of assays particulariy pertinent to cancer research, including cell cycle, cell proliferation, apoptosis, cell viability, cell signaling, stem cell detection, fluorescent protein analysis, and cell phenotyping along with cell sorting. Housing 4 high-speed sorters, 8 color analyzers, 1 Luminex system, 1 cell counter, 1 imaging cytometer, 6 microscopes, and 1 confocal scanning system, FCSR has 5,000 and 13,500 hours/year of cell sorting and analysis capacity, respectively;1,500 hours/year of Luminex capacity;and 12,000 hours/year of microscope-based research capacity. Consultation and Training: FCSR provides a consultation to help those members with little flow cytometry or immunology background to design appropriate experiments. In addition, regular training sessions are held to inform UCCC members and the investigators in their laboratories of new techniques and FCSR capabilities. Many investigators also call FCSR on an ad hoc basis for advice on performing experiments. Utilization: FCSR is among the most popular and most highly used of the UCCC shared resources. More than 100 different Cancer Center members from 6 programs and 7 consortium institutions use either the UCD or the NJH branch facilities. Management and Finances: This resource is UCCC-managed. Currently, 7 1% of the operating budget comes from charge backs to UCCC members who represent 76% of Shared Resource users. FCSR requests $220,370 CCSG support for 2 1% of its operating budget Increased funding will expand assay capabilities and will maintain the FCSR's place at the forefront of cytometry technology as the first Beckman Coulter Cytometry Center of Excellence.

Public Health Relevance

Using flow cytometric analysis, high-speed cell sorting, microscopy, and multiplexed fluorescent microsphere assays, the Flow Cytometry Shared Resource can perform a wide range of assays supporting cancer research, including cell cycle, cell proliferation, apoptosis, cell viability, cell signaling, stem cell detection, fluorescent protein analysis, and cell phenotyping. These assays are crucial to understanding how cancer derails normal cellular processes to cause disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-25
Application #
8567555
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
25
Fiscal Year
2013
Total Cost
$98,464
Indirect Cost
$32,305
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Saichaemchan, S; Ariyawutyakorn, W; Varella-Garcia, M (2016) Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy. Curr Mol Med 16:40-62
Gillen, Austin E; Yamamoto, Tomomi M; Kline, Enos et al. (2016) Improvements to the HITS-CLIP protocol eliminate widespread mispriming artifacts. BMC Genomics 17:338
Justice, Cristina M; Bishop, Kevin; Carrington, Blake et al. (2016) Evaluation of IRX Genes and Conserved Noncoding Elements in a Region on 5p13.3 Linked to Families with Familial Idiopathic Scoliosis and Kyphosis. G3 (Bethesda) 6:1707-12
Eckwahl, Matthew J; Arnion, Helene; Kharytonchyk, Siarhei et al. (2016) Analysis of the human immunodeficiency virus-1 RNA packageome. RNA 22:1228-38
Iguchi, Nao; Malykhina, Anna P; Wilcox, Duncan T (2016) Inhibition of HIF Reduces Bladder Hypertrophy and Improves Bladder Function in Murine Model of Partial Bladder Outlet Obstruction. J Urol 195:1250-6
Seedorf, Gregory; Metoxen, Alexander J; Rock, Robert et al. (2016) Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung. Am J Physiol Lung Cell Mol Physiol 310:L1098-110
Agarwal, Neeraj; Dancik, Garrett M; Goodspeed, Andrew et al. (2016) GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis. Cancer Res 76:5175-85
Helfrich, Barbara A; Kim, Jihye; Gao, Dexiang et al. (2016) Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Mol Cancer Ther 15:2314-2322
Munson, Daniel J; Egelston, Colt A; Chiotti, Kami E et al. (2016) Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. Proc Natl Acad Sci U S A 113:8272-7
Scott, Aaron J; Lieu, Christopher H; Messersmith, Wells A (2016) Therapeutic Approaches to RAS Mutation. Cancer J 22:165-74

Showing the most recent 10 out of 1302 publications